thiophenes has been researched along with phenylephrine hydrochloride in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cawston, TE; Curry, V; Ellis, AJ; Humm, G; Lean, E; Ward, D | 1 |
Arimura, A; Asanuma, F; Deguchi, M; Hirano, Y; Shichijo, M; Yasui, K | 1 |
Bell, SJ; Colagiovanni, DB; Faqi, AS; Gill, S | 1 |
Bi, C; Chu, L; Duan, D; Sun, K; Wang, A; Wu, Z; Xu, L; Yan, X; Yu, X | 1 |
4 other study(ies) available for thiophenes and phenylephrine hydrochloride
Article | Year |
---|---|
Interleukin-1 and oncostatin M in combination promote the release of collagen fragments from bovine nasal cartilage in culture.
Topics: Animals; Cartilage; Cattle; Collagen; Glycoproteins; Glycosaminoglycans; Interleukin-1; Kinetics; Metalloendopeptidases; Nose; Oncostatin M; Peptides; Phenylalanine; Protease Inhibitors; Proteoglycans; Thiophenes; Tissue Inhibitor of Metalloproteinases | 1995 |
Contribution of prostaglandin D2 via prostanoid DP receptor to nasal hyperresponsiveness in guinea pigs repeatedly exposed to antigen.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Administration, Intranasal; Allergens; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Guinea Pigs; Histamine; Male; Nasal Mucosa; Nasal Obstruction; Nose; Ovalbumin; Pressure; Prostaglandin D2; Receptors, Immunologic; Receptors, Prostaglandin; Rhinitis, Allergic, Perennial; Thiophenes; Time Factors | 2008 |
An intranasal irritation assessment of antibacterial ointment alone or in combination with mupirocin versus Bactroban Nasal in rabbits.
Topics: Administration, Intranasal; Animals; Anti-Bacterial Agents; Biological Availability; Diamines; Dose-Response Relationship, Drug; Drug Combinations; Edema; Erythema; Female; Irritants; Male; Mupirocin; Nasal Mucosa; Nose; Ointments; Rabbits; Thiophenes | 2009 |
Lactoferrin-modified rotigotine nanoparticles for enhanced nose-to-brain delivery: LESA-MS/MS-based drug biodistribution, pharmacodynamics, and neuroprotective effects.
Topics: Administration, Intranasal; Animals; Brain; Disease Models, Animal; Dopamine Agonists; Drug Carriers; Drug Delivery Systems; Lactoferrin; Male; Nanoparticles; Neuroprotective Agents; Nose; Parkinson Disease; Rats, Sprague-Dawley; Tandem Mass Spectrometry; Tetrahydronaphthalenes; Thiophenes; Tissue Distribution | 2018 |